These disturbances have implications for lipid clearance, inflammation and insulin sensitivity and suggest that studies are needed to explore whether interventions aimed at regulating complement activation in PCOS may be helpful in reducing cardiometabolic risk. This evidence concerns the gene INS and polycystic ovary syndrome.